The mold conundrum in chronic hyperplastic sinusitis

Current Allergy and Asthma Reports

Volumn 9, Issue 2, 2009, Pages 114-120

  Ebbens, Fenna A ^a   Georgalas, Christos ^b   Fokkens, Wytske J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CATHELICIDIN; CORTICOSTEROID; DEFENSIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; KETOCONAZOLE; LACTOFERRIN; LYSOZYME; PLACEBO; PROTEINASE INHIBITOR; SILVER; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; TERBINAFINE;

ADAPTIVE IMMUNITY; ALTERNARIA; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLUS; AUREOBASIDIUM; CANDIDA; CELL INTERACTION; CLADOSPORIUM; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG DOSAGE FORM COMPARISON; EOSINOPHIL; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUNGUS SPORE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOULD; NEUTROPHIL; NOSE MUCOSA; PARANASAL SINUS; PATHOGENESIS; PENICILLIUM; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RHINOSINUSITIS; SENSITIZATION; SILVER STAINING; THEORY; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHRONIC DISEASE; CYTOKINES; FUNGI; HUMANS; HYPERPLASIA; HYPERSENSITIVITY; IMMUNOTHERAPY; MYCOSES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; SINUSITIS;

EID: 60349130378     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0017-2     Document Type: Review

References (72)

1. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007, 20:1-136.
2. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group: EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007, 45:97-101.
3. Katzenstein AL, Sale SR, Greenberger PA: Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983, 72:89-93.
4. Robson JM, Hogan PG, Benn RA, Gatenby PA: Allergic fungal sinusitis presenting as a paranasal sinus tumour. Aust N Z J Med 1989, 19:351-353.
5. Bent JP III, Kuhn FA: Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994, 111:580-588.
6. deShazo RD, Swain RE: Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995, 96:24-35.
7. Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877-884.
8. Catten MD, Murr AH, Goldstein JA, et al.: Detection of fungi in the nasal mucosa using polymerase chain reaction. Laryngoscope 2001, 111:399-403.
9. Rao AK, Mathers PH, Ramadan HH: Detection of fungi in the sinus mucosa using polymerase chain reaction. Otolaryngol Head Neck Surg 2006, 134:581-585.
10. Polzehl D, Weschta M, Podbielski A, et al.: Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis. J Med Microbiol 2005, 54:31-37.
11. Scheuller MC, Murr AH, Goldberg AN, et al.: Quantitative analysis of fungal DNA in chronic rhinosinusitis. Laryngoscope 2004, 114:467-471.
12. Kim ST, Choi JH, Jeon HG, et al.: Comparison between polymerase chain reaction and fungal culture for the detection of fungi in patients with chronic sinusitis and normal controls. Acta Otolaryngol 2005, 125:72-75.
13. Murr AH, Goldberg AN, Vesper S: Fungal speciation using quantitative polymerase chain reaction (QPCR) in patients with and without chronic rhinosinusitis. Laryngoscope 2006, 116:1342-1348.
14. Weschta M, Rimek D, Formanek M, et al.: Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122-1128.
15. Taylor MJ, Ponikau JU, Sherris DA, et al.: Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002, 127:377-383.
16. Kennedy DW, Kuhn FA, Hamilos DL, et al.: Treatment of chronic rhinosinusitis with high-dose oral terbinafine: A double blind, placebo-controlled study. Laryngoscope 2005, 115:1793-1799.
17. Buzina W, Braun H, Freudenschuss K, et al.: Fungal biodiversity - as found in nasal mucus. Med Mycol 2003, 41: 149-161.
18. Ponikau JU, Sherris DA, Weaver A, Kita HL: Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125-131.
19. Jiang RS, Su MC, Lin JF: Nasal mycology of chronic rhinosinusitis. Am J Rhinol 2005, 19:131-133.
20. Hafidh M, Harney M, Kane R, et al.: The role of fungi in the etiology of chronic rhinosinusitis: A prospective study. Auris Nasus Larynx 2007, 34:185-189.
21. Tosun F, Hidir Y, Saracli MA, et al.: Intranasal fungi and chronic rhinosinusitis: What is the relationship? Ann Otol Rhinol Laryngol 2007, 116:425-429.
22. Aydil U, Kalkanci A, Ceylan A, et al.: Investigation of fungi in massive nasal polyps: Microscopy, culture, polymerase-chain reaction, and serology. Am J Rhinol 2007, 21:417-422.
23. Liang KL, Su MC, Shiao JY, et al.: Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: A randomized, placebo-controlled, double-blind study. Am J Rhinol 2008, 22:52-58.
24. Kostamo K, Richardson M, Virolainen-Julkunen A, et al.: Microbiology of chronic hyperplastic sinusitis. Rhinology 2004, 42:213-218.
25. Granville L,HChirala M, Cernoch P, et al.: Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol 2004, 35:474-481.
26. Gosepath J, Brieger J, Vlachtsis K, Mann WJ: Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 2004, 18:9-13.
27. Braun H, Buzina W, Freudenschuss K, et al.: 'Eosinophilic fungal rhinosinusitis': A common disorder in Europe? Laryngoscope 2003, 113:264-269.
28. Corradini C, Del NM, Buonomo A, et al.: Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 2006, 16:188-193.
29. Ebbens FA, GeWrgalas C, Rinia AB, et al.: The fungal debate: where do we stand today? Rhinology 2007, 45:178-189.
30. Ponikau JU, Sherris DA, Kita H, Kern EB: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002, 110:862-866.
31. Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149-1156.
32. Pant H, Kette FE, Smith WB, et al.: Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005, 115:601-606.
33. Shin SH, Ponikau JA, Sherris DA, et al.: Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004, 114:1369-1375.
34. Ponikau JU, Sherris DA, Kephart GM, et al.: Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 2003, 112:877-882.
35. Ponikau JU, Sherris DA, Kephart GM, et al.: Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005, 116:362-369.
36. Wei JL, Kita H, Sherris DA, et al.: The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 2003, 113:303-306.
37. Griffin E, Hakansson L, Formgren H, et al.: Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients. Allergy 1991, 46:255-265.
38. Koenderman L, van der BT, Schweizer RC, et al.: Eosinophil priming by cytokines: From cellular signal to in vivo modulation. Eur Respir J Suppl 1996, 22:119s-125s.
39. Rainbird MA, Macmillan D, Meeusen EN: Eosinophil-mediated killing of Haemonchus contortus larvae: Effect of eosinophil activation and role of antibody, complement and interleukin-5. Parasite Immunol 1998, 20:93-103.
40. Borish LC, Steinke JW: Cytokines and chemokines. J Allergy Clin Immunol 2003, 111:S460-S475.
41. Haselden BM, Syrigou E, Jones M, et al.: Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. J Allergy Clin Immunol 2001, 108:349-356.
42. Douglas R, Bruhn M, Tan LW, et al.: Response of peripheral blood lymphocytes to fungal extracts and staphylococcal superantigen B in chronic rhinosinusitis. Laryngoscope 2007, 117:411-414.
43. Ooi EH, Wormald PJ, Carney AS, et al.: Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model. Am J Rhinol 2007, 21:367-372.
44. Cole AM, Liao HI, Stuchlik O, et al.: Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 2002, 169:6985-6991.
45. Fukami M, Stierna P, Veress B, Carlsoo B: Lysozyme and lactoferrin in human maxillary sinus mucosa during chronic sinusitis. An immunohistochemical study. Eur Arch Otorhinolaryngol 1993, 250:133-139.
46. CavestrM GM, Ingegnoli AV, Aragona G, et al.: Lactoferrin: mechanism of action, clinical significance and therapeutic relevance. Acta Biomed 2002, 73:71-73.
47. Singh PK, Parsek MR, Greenberg EP, Welsh MJ: A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417:552-555.
48. Healy DY, Leid JG, Sanderson AR, Hunsaker DH: Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008, 138:641-647.
49. Harvey RJ, Lund VJ: Biofilms anS chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology 2007, 45:3-13.
50. Psaltis AJ, Bruhn MA, Ooi EH, et al.: Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope 2007, 117:2030-2035.
51. Psaltis AJ, Wormald PJ, Ha KR, Tan LW: Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 2008, 118:895-901.
52. Crouch E, Hartshorn K, Ofek I: Collectins and pulmonary innate immunity. Immunol Rev 2000, 173:52-65.
53. Ooi EH, Wormald PJ, Carney AS, et al.: Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model. Laryngoscope 2007, 117:51-57.
54. Vroling AB, Fokkens WJ, van Drunen CM: How epithelial cells detect danger: Aiding the immune response. Allergy 2008, 63:1110-1123.
55. Kauffman HF, Tomee JF, van de Riet MA, et al.: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000, 105:1185-1193.
56. Reed CE, Kita H: The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004, 114:997-1008.
57. Yoon J, Ponikau JU, Lawrence CB, Kita H: Innate antifungal immunity of human eosinophils mediated by a beta2 integrin, CD11b. J Immunol 2008, 181:2907-2915.
58. Inoue Y, Matsuwaki Y, Shin SH, et al.: Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005, 175:5439-5447.
59. Bent JP III, Kuhn FA: Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 1996, 106:1331-1334.
60. Kfoury AG, Smith JC, Farhoud HH, et al.: Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Clin Transplant 1997, 11:608-612.
61. Leu HS, Huang CT: Clearance of funguria with short-course antifungal regimens: A prospective, randomized, controlled study. Clin Infect Dis 1995, 20:1152-1157.
62. Ricchetti A, Landis BN, Maffioli A, et al.: Effect of antifungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261-263.
63. Helbling A, Baumann A, Hanni C, Caversaccio M: Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 2006, 120:1023-1025.
64. Shirazi MA, Stankiewicz JA, Kammeyer P: Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol 2007, 21:145-148.
65. Rains BM III, Mineck CW: Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003, 17:1-8.
66. Jornot L, Rochat T, Lacroix JS: Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 2003, 41:201-205.
67. Shin SH, Ye MK: Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 2004, 124:1174-1177.
68. Weschta M, Rimek D, Formanek M, et al.: Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006, 132:743-747.
69. Ebbens FA, Georgalas C, Luiten S, et al.: The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: A multicenter randomised controlled study. Laryngoscope 2009 (in press).
70. Mabry RL, Marple BF, Folker RJ, Mabry CS: Immunotherapy for allergic fungal sinusitis: Three years' experience. Otolaryngol Head Neck Surg 1998, 119:648-651.
71. Mabry RL, Marple BF, Mabry CS: Outcomes after discontinuing immunotherapy for allergic fungal sinusitis. Otolaryngol Head Neck Surg 2000, 122:104-106.
72. Ebbens FA, GeWrgalas C, Rinia AB, et al.: The fungal debate: where do we stand today? Rhinology 2007, 45:178-189.